4,4,5,5-Tetramethyl-2-(3-methyl-4-nitrophenyl)-1,3,2-dioxaborolane, 95+%, 5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((2,2,10,10-tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene)amino)pentanoic acid, 95%, 1g

2-Phenyl-1 H -benzoimidazol-4-ylamine, 250mg

2-[Difluoro-(3,4,5-trifluorophenoxy)methyl]-1,3-difluoro-5-(4-propylphenyl)benzene, 97%, 100g

tert-Butyl ((3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxetan-3-yl)methyl)carbamate, 98%, 100mg

2-Nitrofluorene>99.0%(HPLC)25g

2-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one, 95%, 5g

tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate, 95.0%, 1g

(Z)-4-AMINO-N-(3-BROMO-4-FLUOROPHENYL)-N'-HYDROXY-1,2,5-OXADIAZOLE-3-CARBOXIMIDAMIDE, 95.0%, 10g

ETHYL 3-(4-METHOXYPHENYL)-1H-PYRAZOLE-5-CARBOXYLATE, 95.0%, 250mg

Liothyronine, 95+%, 500mg

1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine, 500mg

1,3-Dibromo-5-(2,2,2-trifluoroethyl)benzene, 98.0%, 5g